U.S. FDA Inamrinone Lactate Registration | FDA Regulatory Assistance for Food, Medical Device, Drug & Cosmetic Companies

HOME FOOD AND BEVERAGES DRUGS

Drug Listing Labeling and Ingredients Reviews Drug Master Files Certificate of Registration

COSMETICS MEDICAL DEVICES ELECTRONICS FEES WORLDWIDE OFFICES CONTACT US

Home › Drugs › U.S. FDA Active Pharmaceutical Ingredients (API) › API Examples › U.S. FDA Regulations: Inamrinone Lactate

U.S. FDA Requirements: Inamrinone Lactate

Pharmaceutical / Drug Definition : Inhibits cyclic adenosine monophosphate (cAMP) phosphodiesterase activity in myocardium, increasing cellular levels of cAMP (which regulates intracellular and extracellular calcium levels). These actions increase myocardial contraction force. Also relaxes and dilates vascular smooth muscle, decreasing preload and afterload.

Registrar Corp assists Inamrinone Lactate companies with:

FDA Registration Inamrinone Lactate
FDA Listing Inamrinone Lactate
FDA Label Requirements and Exceptions Inamrinone Lactate
FDA Import Information Inamrinone Lactate
FDA Detentions Inamrinone Lactate (Inamrinone Lactate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
   - Manufacturers Inamrinone Lactate (Inamrinone Lactate Suppliers)
   - Processors Inamrinone Lactate
   - Repackers Inamrinone Lactate
   - Relabelers Inamrinone Lactate
   - Exporters Inamrinone Lactate
   - Importers Inamrinone Lactate

For more information about Inamrinone Lactate, simply click below:

U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207

Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.


	Home \| About Us \| News \| Resources \| Exhibitions \| Seminars \| Associations \| Careers \| Sitemap \| Terms of Use	© 2013 Registrar Corp